☆ 4.7 Letter

No excess mortality in contemporary undifferentiated arthritis, in contrast to rheumatoid arthritis: a study with a follow-up of at least 10 years

ANNALS OF THE RHEUMATIC DISEASES (2022)

Related references

Note: Only part of the references are listed.
Article Rheumatology

Undifferentiated arthritis: a changing population who did not benefit from enhanced disease-modifying anti-rheumatic drug strategies-results from a 25 year longitudinal inception cohort

Marloes Verstappen et al.

Summary: International guidelines emphasize the timely initiation of DMARD treatment for early arthritis, but the definition of contemporary undifferentiated arthritis (UA) has changed and there is a lack of placebo-controlled trials on DMARD efficacy. This study found that although intensified DMARD treatment slightly improved disease activity scores, physical functioning and long-term outcomes did not improve.

RHEUMATOLOGY (2022)

Add to Collection
Letter Rheumatology

Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA

Xanthe M. E. Matthijssen et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

Add to Collection
Article Rheumatology

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab

Joachim Listing et al.

ANNALS OF THE RHEUMATIC DISEASES (2015)

Add to Collection
Review Rheumatology

Mortality in rheumatoid arthritis over the last fifty years: Systematic review and meta-analysis

Sabrina Dadoun et al.

JOINT BONE SPINE (2013)

Add to Collection
Article Rheumatology

Criteria for early rheumatoid arthritis - From Bayes' law revisited to new thoughts on pathogenesis

TWJ Huizinga et al.

ARTHRITIS AND RHEUMATISM (2002)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.